These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 3313326)
1. Evaluation of the metabolizing capacity of S9 liver preparations from rats and mice using a test with Salmonella typhimurium TA100. Gajcy H; Pieńkowska K; Koziorowska J; Czarnomska A Pol J Pharmacol Pharm; 1987; 39(1):27-32. PubMed ID: 3313326 [TBL] [Abstract][Full Text] [Related]
2. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds. Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387 [TBL] [Abstract][Full Text] [Related]
3. [Study of promutagen biotransformation in the Ames test. III. The role of conjugation with glucuronic acid and sulfate in the modification of mutagenic effect of nitrosomorpholine, diethylnitrosamine and cyclophosphamide]. Loknitskaia NN; Rotenberg IuS; Fonshteĭn LM; Shuliakovskaia TS Genetika; 1986 Sep; 22(9):2259-64. PubMed ID: 3533722 [TBL] [Abstract][Full Text] [Related]
4. [Metabolic activation of p-nitrotoluene and trichloroethylene by rat-liver S9 or mouse-liver S9 fractions in Salmonella typhimurium strains (author's transl)]. Miyata R; Nohmi T; Yoshikawa K; Ishidate M Eisei Shikenjo Hokoku; 1981; 99():60-5. PubMed ID: 7037091 [No Abstract] [Full Text] [Related]
5. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice. Irwin RD Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105 [TBL] [Abstract][Full Text] [Related]
6. Greater effectiveness of hepatocyte and liver S9 preparations from hamsters than rat preparations in activating N-nitroso compounds to metabolites mutagenic to Salmonella. Raineri R; Poiley JA; Andrews AW; Pienta RJ; Lijinsky W J Natl Cancer Inst; 1981 Nov; 67(5):1117-22. PubMed ID: 6946249 [TBL] [Abstract][Full Text] [Related]
7. A study on the mutagenic effect of some Bulgarian drugs using the Salmonella/microsome test. Dimitrova K; Ivanov V; Bogoeva M; Golovinsky E; Markov K Acta Physiol Pharmacol Bulg; 1983; 9(4):31-6. PubMed ID: 6375259 [TBL] [Abstract][Full Text] [Related]
8. [Butylhydroxytoluene inhibition of the mutagenic activity of carcinogenic nitroso compounds and cyclophosphamide: the role of the glutathione conjugation reaction]. Kalinina EV; Loknitskaia NN; Shuliakovskaia TS; Fonshteĭn LM Vopr Onkol; 1987; 33(9):59-63. PubMed ID: 3310399 [TBL] [Abstract][Full Text] [Related]
9. Bioactivation of promutagens by the unicellular green alga Chlamydomonas reinhardtii. Podstavková S; Vlcek D; Miadoková E J Environ Pathol Toxicol Oncol; 1997; 16(1):21-6. PubMed ID: 9256928 [TBL] [Abstract][Full Text] [Related]
10. [Metabolic activation of promutagens in the yeast-microsome test. II. Activation of cyclophosphamide and 2-aminofluorene]. Pavlov IuI; Khromov-Borisov NN Genetika; 1983 Mar; 19(3):362-74. PubMed ID: 6343182 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclophosphamide mutagenicity by beta-carotene. Belisario MA; Pecce R; Battista C; Panza N; Pacilio G Biomed Pharmacother; 1985; 39(8):445-8. PubMed ID: 3914914 [TBL] [Abstract][Full Text] [Related]
12. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test. Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239 [TBL] [Abstract][Full Text] [Related]
13. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay. Prival MJ; Mitchell VD Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474 [TBL] [Abstract][Full Text] [Related]
14. [Study of the process of promutagen biotransformation by the Ames test. I. The role of conjugation with glutathione in the modification of the mutagenic activity of nitrosomorpholine, diethylnitrosamine and cyclophosphamide]. Fonshteĭn LM; Loknitskaia NN; Rotenberg IuS Genetika; 1985 Nov; 21(11):1821-7. PubMed ID: 3908219 [TBL] [Abstract][Full Text] [Related]
15. Antiperoxidative, anti-inflammatory, and antimutagenic activities of ethanol extract of the mycelium of Ganoderma lucidum occurring in South India. Lakshmi B; Ajith TA; Sheena N; Gunapalan N; Janardhanan KK Teratog Carcinog Mutagen; 2003; Suppl 1():85-97. PubMed ID: 12616600 [TBL] [Abstract][Full Text] [Related]
16. Comparison of mutagenicities of N-nitrosamines on Salmonella typhimurium TA100 and Escherichia coli WP2 uvrA/pKM101 using rat and hamster liver s9. Araki A; Muramatsu M; Matsushima T Gan; 1984 Jan; 75(1):8-16. PubMed ID: 6373472 [TBL] [Abstract][Full Text] [Related]
17. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261 [TBL] [Abstract][Full Text] [Related]
18. Modification of the mutagenicity and teratogenicity of cyclophosphamide in rats with inducers of the cytochromes P-450. Hales BF Teratology; 1981 Aug; 24(1):1-11. PubMed ID: 7029774 [TBL] [Abstract][Full Text] [Related]
19. Mutagenicity of carbon tetrachloride and chloroform in Salmonella typhimurium TA98, TA100, TA1535, and TA1537, and Escherichia coli WP2uvrA/pKM101 and WP2/pKM101, using a gas exposure method. Araki A; Kamigaito N; Sasaki T; Matsushima T Environ Mol Mutagen; 2004; 43(2):128-33. PubMed ID: 14991753 [TBL] [Abstract][Full Text] [Related]
20. Mutagenicity of beta-glucuronidase in the Ames test. Cerná M Mutat Res; 1985 Jul; 143(3):169-72. PubMed ID: 3892278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]